Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Gaotong Isotope is a leading Chinese developer and manufacturer of radiopharmaceuticals and medical radioisotopes, with commercial-scale GMP production and programs in both diagnostic and therapeutic imaging and therapy. The company supplies crucial isotopes (e.g., no-carrier-added 177Lu) to China's oncology and nuclear medicine sector, and is a key enabler for targeted radiotherapeutics and diagnostic radiopharmaceuticals. Its clinical output includes supply and co-development of established and next-generation radioisotopes and radiopharmaceuticals for hospitals and pharmaceutical companies across China.[1][6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Gaotong Isotope.